MML Investors Services’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
TBC
TCM
PA
MML Investors Services's IONS Position: Q2 2026 in Review
MML Investors Services increased its Ionis Pharmaceuticals (IONS) stake by 13% in Q2 2026, buying an estimated $32.1K and bringing the position to 3,600 shares worth $285K. The position accounts for ﹤0.01% of the portfolio, ranked #2858.
MML Investors Services first reported a position in IONS in Q3 2018 and has held it in 16 quarters since. The position peaked at $1.09M in Q2 2022. 218 funds tracked by Wall St. Rank hold IONS as of Q2 2026.
- MML Investors Services held 3,600 shares of Ionis Pharmaceuticals worth $285K as of Q2 2026.
- MML Investors Services bought 427 Ionis Pharmaceuticals shares in Q2 2026, an estimated $32.1K.
- Ionis Pharmaceuticals made up ﹤0.01% of MML Investors Services's portfolio in Q2 2026, its #2858 holding.
- MML Investors Services first reported a position in Ionis Pharmaceuticals in Q3 2018 and has held it in 16 quarters since.
- MML Investors Services's Ionis Pharmaceuticals position peaked at $1.09M in Q2 2022.
- 218 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.
Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.